The big miners were sprung for their Singapore profits sling, and the United States tech giants shown up for their Byzantine tax structures, but there was little time left to spend on other sectors where multinational tax chicanery was rife. When the Senate Inquiry into Corporate Tax Avoidance reconvened to tie up some loose ends last month though, … Continue reading Big pharma shuffles the tax pill